AIM: To evaluate the expression of apoptosis related gene Fas ligand (FasL) in human hepatocellular carcinoma (HCC) cells HepG2 and its significance in apoptosis. METHODS: Levels of soluble Fas ligand (sFasL) in a group of patients with hepatitis B virus (HBV)-induced chronic hepatitis, HBV-positive liver cirrhosis and HCC were evaluated. In a further study, the recombinant eukaryotic expression plasmid pcDNA3.1hisB-FasL was transfected into HCC cells HepG2 by lipofection, and then soluble FasL was examined in the supernatant of culture cells by EIA, FasL expression in HepG2 cells was detected by immunohistochemistry. After being stained by annexin V and propidium iodine, cells were passed through a flow cytometer and examined by a fluorescence microscope and a laser scanning microscope. RESULTS: The sFasL levels were significantly lower in patients with HCC when compared to the patients with hepatitis or liver cirrhosis. In comparison with untransfected cells, the soluble FasL could be detected in the supernatant of transfected cells. FasL was expressed on the membranes and cytoplasm of transfected cells. The apoptotic cell rate was 36.30% in transfected cells, and was 11.53% in untransfected cells. Moreover, the different stage of apoptotic cells could be distinguished by annexin V and propidium iodine staining. CONCLUSION: Fas ligand is an apoptotic pathway of HCC cells.
AIM: To evaluate the expression of apoptosis related gene Fas ligand (FasL) in humanhepatocellular carcinoma (HCC) cells HepG2 and its significance in apoptosis. METHODS: Levels of soluble Fas ligand (sFasL) in a group of patients with hepatitis B virus (HBV)-induced chronic hepatitis, HBV-positive liver cirrhosis and HCC were evaluated. In a further study, the recombinant eukaryotic expression plasmid pcDNA3.1hisB-FasL was transfected into HCC cells HepG2 by lipofection, and then soluble FasL was examined in the supernatant of culture cells by EIA, FasL expression in HepG2 cells was detected by immunohistochemistry. After being stained by annexin V and propidium iodine, cells were passed through a flow cytometer and examined by a fluorescence microscope and a laser scanning microscope. RESULTS: The sFasL levels were significantly lower in patients with HCC when compared to the patients with hepatitis or liver cirrhosis. In comparison with untransfected cells, the soluble FasL could be detected in the supernatant of transfected cells. FasL was expressed on the membranes and cytoplasm of transfected cells. The apoptotic cell rate was 36.30% in transfected cells, and was 11.53% in untransfected cells. Moreover, the different stage of apoptotic cells could be distinguished by annexin V and propidium iodine staining. CONCLUSION:Fas ligand is an apoptotic pathway of HCC cells.
Authors: G Demir; M Ozguroglu; N Sayhan; N Molinas-Mandel; F Demirelli; E Buyukunal; N Tuzuner; S Serdengecti; B Berkarda Journal: Anticancer Res Date: 1999 Jul-Aug Impact factor: 2.480
Authors: Y Fukuzawa; K Takahashi; K Furuta; T Tagaya; T Ishikawa; K Wada; Y Omoto; T Koji; S Kakumu Journal: J Gastroenterol Date: 2001-10 Impact factor: 7.527
Authors: S Sugita; C Taguchi; H Takase; K Sagawa; J Sueda; K Fukushi; N Hikita; T Watanabe; K Itoh; M Mochizuki Journal: Br J Ophthalmol Date: 2000-10 Impact factor: 4.638
Authors: Mohamed Tarek M Shata; Enass A Abdel-Hameed; Susan D Rouster; Li Yu; Meina Liang; Esther Song; Mark T Esser; Norah Shire; Kenneth E Sherman Journal: Pathog Immun Date: 2019-02-13
Authors: Sanrong Xu; Penghao Shu; Song Zou; Xiaofeng Shen; Yuanqian Qu; Yong Zhang; Kang Sun; Jin Zhang Journal: Cancer Med Date: 2018-08-07 Impact factor: 4.452